Terms Defined Elsewhere Clause Samples

POPULAR SAMPLE Copied 1 times
Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: Acquisition 7.3(d) Agreement Preamble Apogent Preamble Apogent Balance Sheet 3.1(d)(iv) Apogent Benefit Plans 3.1(i)(i) Apogent Bylaws 3.1(a)(ii) Apogent Charter 3.1(a)(ii) Apogent Common Stock 2.1 Apogent Disclosure Schedule 3.1 Apogent Leased Real Property 3.1(r) Apogent Material Contract 3.1(q)(i) Apogent Option 2.1(d) Apogent Organizational Documents 3.1(a)(ii) Apogent Owned Real Property 3.1(r) Apogent Permits 3.1(g)(i) Apogent Preferred Stock 3.1(b)(i) Apogent Purchase Plan 2.1(d) Apogent Restricted Stock Unit 5.11(a)(ii) Apogent Rights 3.1(b)(i) Apogent Rights Agreement 3.1(b)(i) Apogent SEC Documents 3.1(d)(i) Apogent Shareholder Approval 3.1(c)(iii) Apogent Shareholders’ Meeting 5.1(b) Apogent Significant Subsidiaries 3.1(a)(iii) Apogent Stock Plans 3.1(b)(i) Apogent Subsidiary Organizational Documents 3.1(a)(ii) Apogent Termination Fee 7.3(a) Apogent Third Party Bidder 7.3(a)(i) Applicable Laws 3.1(g)(ii) Approval 3.1(i)(ii) Articles of Merger 1.3 Benefit Continuation Period 5.11(c) Benefit Plans 3.1(i)(i) CDA 4.2(c)(i) Certificates 2.2(b) Change of Recommendation 4.2(d)(ii) Closing 1.2 Closing Date 1.2 Code Recitals DFI 1.3 Effect 8.3(k) Effective Time 1.3 ERISA 3.1(i)(i) ERISA Affiliate 3.1(i)(v) Exchange Act 3.1(c)(v)(B)(2) Exchange Agent 2.2(a) (a) Exchange Ratio 2.1(a) FDA 3.1(g)(i)
Terms Defined Elsewhere. Each of the following capitalized terms, when used in this Agreement, has the meaning provided for such term in the Section of this Agreement set forth beside such term below: Term Section Additional Interests 3.05(b) Adjusted Capital Account Exhibit C Aggregate Consideration 8.03(b) Authorized Person 2.01 Board 5.01(a) Capital Account 3.03 Closing 10.03 Company Introductory Paragraph Company Minimum Gain Exhibit C Company Tax Rep 4.04(c) Dissolution Event 9.01(a) Distribution Threshold 2.09(c) Existing Owners 3.05(c) Firm 11.14 IPO 3.05(b) Later Year 4.04(c) Majority Member Introductory Paragraph Member Nonrecourse Debt Exhibit C Member Nonrecourse Debt Minimum Gain Exhibit C Member Nonrecourse Deductions Exhibit C Minority Member Representative 5.02(a) Nonrecourse Deductions Exhibit C Nonrecourse Liability Exhibit C Partnership Representative 4.04(c) Public Safety 8.01 Put Notice 10.01 Representative 5.01(a) Redemption Price 10.02 Safe Harbor Election 4.08 Tax Distributions 4.02(b) Tax Matters Member 4.04(c) Transfer 8.01 Transfer Notice 8.02(a) Transferor 8.02(a) Ultimate Rules 4.08 Unitholder 4.04(c) Units Sale 8.03(a)
Terms Defined Elsewhere. The following is a list of additional terms used in this Agreement and a reference to the Section hereof in which such term is defined: Acquisition Sub Preamble Aggregate Loss Threshold Section 8.3(a) Agreement Preamble Available NOL Amount Section 2.15(c) CIC Amendment Section 5.14(b) Claim Notice Section 8.4(a) Closing Section 2.3(a) Closing Date Section 2.3(a) Closing Working Capital Section 2.13(a)(i) Company Preamble Company Disclosure Schedule Article III Company Intellectual Property Section 3.17(a) Credits Section 2.15(a) Damages Section 8.2(a), (c) Decline Date Section 2.13(d) DGCL Section 2.1 Dispute Notice Section 8.4(b) Disputed Line Items Section 2.13(d) Dissenting Shares Section 2.16(a) Dissenting Shares Reduction Amount Section 2.16(b) Effective Time Section 2.2 Equityholder Indemnified Parties Section 8.2(b) Estimated Working Capital Section 2.13(b) Estimated Working Capital Adjustment Section 2.13(b) Final Working Capital Adjustment Section 2.13(e) Form Working Capital Statement Section 2.13(a)(i) General Survival Date Section 8.1 Hireworks Section 5.15 Indemnified Officers Section 5.10 Indemnified Party Section 8.4(a) Indemnitor Section 8.4(b) Initial Calculation Section 2.13(c) Kenexa Indemnified Parties Section 8.2(a) Kenexa Technology Preamble Labor Union Section 3.16(a)(i) Letter of Transmittal Section 2.10(b) Material Contracts Section 3.6(a) Merger Section 2.1 Merger Certificate Section 2.2 Net Adjustment Amount Section 2.13(f) NOL Adjustment Amount Section 2.15(c) NOL Study Section 2.15(b) NOLs Section 2.15(a) Notice of Disagreement Section 2.13(d) Notice of NOL Disagreement Section 2.15(c) Option Cancellation Agreement Section 2.11 Option Holder Section 3.4(c) Outside Date Section 7.1(b) Parent Preamble Pre-Closing Taxes Section 5.11(a) Relevant Group Section 3.10(a)(i) Representative Preamble Representative Agreement Section 8.8(a) Representative Parties Section 8.8(f)(iii) Settlement Accountants Section 2.13(d) Stockholder Approval Section 3.3(b) Straddle Period Section 5.11(a) Surviving Corporation Section 2.1 Targeted Credit Amount Section 2.15(a) Targeted NOL Amount Section 2.15(a) Tax or Taxes Section 3.10(a)(ii) Tax Return Section 3.10(a)(iii) Terminated Plan Section 3.16(b)(i) Transaction Expense Statement Section 2.9(a) Transfer Taxes Section 3.10(a)(iv)
Terms Defined Elsewhere. As used in this Agreement, the following capitalized terms are defined in this Agreement as referenced in the following table: Agreement Preamble Amendment to the Company Management Agreement Recitals Articles of Merger 2.2(b) Book-Entry Shares 3.3(b)(i) Cancelled Shares 3.1(b)(v) Certificate of Merger 2.2(b) Certificates 3.3(b)(i) Closing 2.2(a) Closing Date 2.2(a) Code Recitals Company Preamble Company Additional Dividend Amount 6.19(a) Company Affiliate 9.10(a) Company Board Recitals Company Board Recommendation Recitals Company Change of Recommendation 6.3(b) Company Common Stock 3.1(b)(i) Company Contracts 3.2(b) Company DER Consideration 3.2(b) Company Director Designee 2.6 Company Disclosure Letter Article IV Company Dividend Equivalent Right 3.2(b) Company Material Adverse Effect 4.1(a) Company Permits 4.9 Company Plans 4.10(a) Company SEC Documents 4.5(a) Company Series A Preferred Stock 3.1(b)(iii) Company Series B Preferred Stock 3.1(b)(iii) Company Series C Preferred Stock 3.1(b)(iii) Company Special Committee Recitals Company Stockholders Recitals Company Stockholders Meeting 4.4 Confidentiality Agreement 6.7(b) Creditors’ Rights 4.3(a) Delaware LLC Act 2.1 Delaware Secretary of State 2.2(b) e-mail 9.3 Effective Time 2.2(b) End Date 8.1(b)(ii) Exchange Agent 3.3(a) Exchange Fund 3.3(a) Forfeited Phantom Shares 3.2(a) GAAP 4.5(b) Indemnified Liabilities 6.10(a) Indemnified Persons 6.10(a) Joint Proxy Statement 4.4 Letter of Transmittal 3.3(b)(i) Leverage Covenants 6.1(a)(xiv) Maryland Courts 9.7(b) Maryland Department 2.2(b) Material Company Insurance Policies 4.17 Material Parent Insurance Policies 5.17 Merger Recitals Merger Filings 2.2(b) Merger Sub Preamble Merger Sub Sole Member Recitals MGCL 2.1 Operating Partnership 2.1 Parent Preamble Parent Additional Dividend Amount 6.19(b) Parent Affiliate 9.10(b) Parent Board Recitals Parent Board Recommendation 5.3(a) Parent Change of Recommendation 6.4(b) Parent Common Stock Issuance Recitals Parent Contracts 5.16(b) Parent Disclosure Letter Article V Parent Equity Plan 5.2(a) Parent Management Agreement Amendment Recitals Parent Manager Recitals Parent Material Adverse Effect 5.1(a) Parent Permits 5.9 Parent Plans 5.10(a) Parent SEC Documents 5.5(a) Parent Stock Issuance Recitals Parent Stockholders Recitals .pdf 9.5 Per Share Common Merger Consideration 3.1(b)(i) Per Share Preferred Merger Consideration 3.1(b)(iii) Per Share Preferred Series B Merger Consideration 3.1(b)(iii) Per Share Preferred...
Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below:
Terms Defined Elsewhere. The following is a list of additional terms used in this Agreement and a reference to the Section hereof in which such term is defined: Agreement Preamble Biogen Idec License Agreement Section 4.7 Biogen Idec Supply Agreement Section 4.7 Books and Records Section 2.12(f)(2) Claim Notice Section 8.3(a) Closing Section 2.3 Closing Date Section 2.3 Company Preamble Company Common Stock Section 2.8 Company Disclosure Schedule Article IV Company Expenses Schedule Section 2.13 Company Indemnified Parties Section 8.2(a)(ii) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c) Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties Section 8.2(a)(i) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g)
Terms Defined Elsewhere. For purposes of this Agreement, the following terms (as capitalized below) will have the following meanings when used in this Agreement: Action Section 6.10(b) Agreement Preamble Alternative Acquisition Agreement Section 6.04(a) Alternative Proposal Section 6.04(i) Annual Bonus Section 6.06(e) Approval Request Section 6.01(b) Articles of Merger Section 2.03 Book-Entry Shares Section 3.01(a) Burdensome Condition Section 6.07(d) Capex Budget Section 4.13(a)(i) Certificate of Merger Section 2.03 Certificates Section 3.01(a) Change of Recommendation Section 6.04(f) Closing Section 2.02 Closing Date Section 2.02 Code Section 3.02(b)(iii) Common Stock Section 3.01(a) Company Preamble Company Board Recitals Company Disclosure Letter Article IV Company Employee Section 6.06(a) Company Employees Section 6.06(a) Company Incentive Plan Section 6.06(e) Company Product Section 4.21 Company Related Parties Section 8.03(a) Company SEC Reports Section 4.06(a) Company Shareholders’ Meeting Section 6.05(b) Confidentiality Agreement Section 6.03(b) control Definition of Affiliates, Section 1.01 controlled by Definition of Affiliates, Section 1.01 DGCL Section 2.01 Dissenting Shares Section 3.01(c)(ii) Effective Time Section 2.03 End Date Section 8.01(b) Enforcement Expenses Section 8.03(b) Exchange Fund Section 3.02(a) First Extended Date Section 8.01(b) G▇▇▇▇▇▇ S▇▇▇▇ Section 4.25 Indemnified Party Section 6.10(b) Intervening Event Section 6.04(k) Intervening Event Notice Section 6.04(g) Leases Section 4.10(b) Legal Restraint Section 7.01(b) Mass Layoff Section 4.18(a) Material Contract Section 4.13(a) Maximum Amount Section 6.10(c) Measurement Time Section 4.02(a) Merger Recitals Merger Consideration Section 3.01(a) Merger Sub Preamble Multiemployer Plan Section 4.18(j) New Plans Section 6.06(b) Notice Period Section 6.04(f) OFAC Definition of Sanctions, Section 1.01 Old Plans Section 6.06(b) Oregon Act Section 2.01 Owned Real Property Section 4.10(a) Parent Preamble Parent Material Adverse Effect Section 5.01 Parent Related Parties Section 8.03(a) Parties Preamble Party Preamble Paying Agent Section 3.02(a) Payoff Amount Section 6.18 Payoff Letter Section 6.18 Plant Closing Section 4.18(a) President Definition of CFIUS Approval, Section 1.01 Recommendation Section 4.04 Remedial Action Section 6.07(d) Replacement Credit Facility Section 6.01(a)(x)(A)(v) Required Company Shareholder Vote Section 4.24 Sanctioned Countries Definition of Sanctions Target, Section 1.01 Share Sec...
Terms Defined Elsewhere. The following terms are defined herein in the sections identified below:
Terms Defined Elsewhere. The following terms are defined in this Agreement as follows: “Agreement” Preamble
Terms Defined Elsewhere. The following terms are defined elsewhere in this Agreement, as indicated below: “Adverse Action” Section 4.6.2 “Agreement” Recitals “Certificate of Merger” Section 2.4 “Certificates” Section 3.2.2